Post Profile






Related Posts


Is Now a Good Time to Buy Merck & Co., Inc. (MRK) Stock?

Business & Finance / Investing : Insider Monkey

Merck & Co., Inc. (NYSE:MRK) has had its fair share of bad news recently. Shares have pulled back around 5% in June. Could this bad news actually present a good time to buy Merck & Co., Inc. (NYSE:MRK) stock? Let’s take a look. Bad ...

Merck & Co., Inc. (MRK) Stock Depends on Januvia More Than Ever

Business & Finance / Investing : Insider Monkey

Merck & Co., Inc. (NYSE:MRK) stock has become dependent on its diabetes drug Januvia over the past couple of years for revenue growth. The franchise made up 12% of Merck & Co., Inc. (NYSE:MRK)’s sales in the first quarter and probab...

Merck & Co., Inc. (MRK)’s Late-Stage Breakdown

Business & Finance / Investing : Insider Monkey

The Food and Drug Administration cancelled an advisory meeting planned for Merck & Co., Inc. (NYSE:MRK)’s post-surgery drug sugammadex. It’s another blow to Merck & Co., Inc. (NYSE:MRK) as investors pay close attention to the beleag...

Merck & Co., Inc. (MRK), Pfizer Inc. (PFE): Does This Pipeline Promise Tomorrow’s Blockbuster Sales?

Business & Finance / Investing : Insider Monkey

Nearly every big pharma player has been hit with patent expirations that have hit hard on sales lately, and Merck & Co., Inc. (NYSE:MRK) is no exception. Merck & Co., Inc. (NYSE:MRK)’s one of the industry’s biggest giants, but the l...

Merck & Co., Inc. (MRK): Post-Earnings Performance Questions

Business & Finance / Investing : Insider Monkey

Merck & Co., Inc. (NYSE:MRK) stock could move up or down this week after the pharmaceutical company reports earnings on Wednesday. Here’s a look at what to expect and the biggest divers of the price for Merck & Co., Inc. (NYSE:MRK) ...

Comments


Copyright © 2016 Regator, LLC